impact of glp-1 drugs on industries Agonists Weight Loss Market Report, 2025-2030 Chart: 1 in 8 Americans
Description
Manipulated Labels, Word Filters & Bans
Do not apply heat directly over the patch
Berberine (BBR) exhibits significant anti-diabetic effects by enhancing insulin sensitivity, promoting glycolysis, and inhibiting gluconeogenesis
Maximize your GLP-1 results
The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.
Acccording to the Route of Administration, the market is segmented into Parenteral, and Oral
